The objective of the BioMILD study is to evaluate the efficacy of a CT scan plus plasma microRNA profiling as the initial screening test for the detection of lung cancer in heavy smokers.
Previously, the MILD trial by the same investigators showed the benefits of prolonging the screening period, and now they hypothesize that microRNA profiling in the first instance will lead to a reduction in the number of false-positive cases.
Results
Ugo Pastorino outlines the study and it's key findings explains that the study demonstrated that the screening test can improve the results by separating individuals with different risk of lung cancer at the same exposure and age (3:09):